Lv1
40 积分 2024-07-10 加入
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
13天前
已完结
Measuring Circulating Complement Activation Products in Myeloperoxidase– and Proteinase 3–Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
14天前
已完结
Glomerular Diseases
15天前
已关闭
Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria
18天前
已完结
Membranous nephropathy
19天前
已完结
The Complement System in Lupus Nephritis
21天前
已完结
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies
22天前
已完结
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders
22天前
已完结
Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy
26天前
已完结
Current Biomarkers of IgA Nephropathy
1个月前
已完结
皖公网安备34019202002308
